江宁军

新闻

相关新闻

  1. The biotech company has been dogged by multiple challenges recently, including declining revenue, ongoing losses and a recent rejection by one of its overseas partners.
    君实生物换研发背景新帅 能否挽救低迷业绩表现？
    1877.HK 688180.SHG
  2. AI制药烧钱迅速 英矽智能再冲港股
掌握中概股最新动态，订阅我们的新闻邮件

关注我们

Facebook Twitter Linkedin Weixin Weibo Youtube

免费订阅新闻邮件

订阅邮件

在以下平台浏览我们的新闻

factiva